Global Bioimpedance Analyzers Market Overview

The Global Bioimpedance Analyzers market was valued at USD 465.58 million in 2021 and is expected to reach USD 836.45 million by the year 2028, at a CAGR of 8.73%.

Bioimpedance Analyzers (BIA) are referred to as the screening tool that can be applied to measure and correctly analyze body composition and body fat. It is a non-invasive tool utilized by medical practitioners to measure the percentage of body fat. It also allows the estimation of the percentage of muscle tissues, percentage of hydration levels, metabolic rate, bone weight, and fitness levels. There are a variety of methods utilized for the clarification of measured bioimpedance data and an extensive range of applications of bioimpedance in body composition estimation. Bioimpedance Analyzers act on the principle of electrical conductivity. Bioimpedance Analyzers is rising in popularity owing to their convenience and the extensive range of parameters it can monitor. The test involves placing two electrodes on a person's right hand and foot. A low-level and imperceptible electrical current is sent via the body. The flow of the current through a patient's body is influenced by the amount of water composition. The device fundamentally measures how this signal is hampered through various kinds of tissue. The tissues that comprise large amounts of fluid and electrolytes, such as blood, generally have high conductivity. Additionally, fat and bone slow the signal down. Since Bioimpedance Analyzers is utilized to determine the resistance to flow of the current as it passes through the body, it can offer estimates of body water from which body fat is then calculated using specific tools. Many companies such as Zurich Instruments AG and Tanita produce the Bioimpedance Analyzers devices.

For instance, one of Tanita's flagship products, the BF679W, can be utilized to measure a patient's bio-impedance. This can then be applied for measuring muscle mass, body fat percentage, muscle quality, and visceral fat. Additionally, body composition analyzers can be used in different settings. Hospitals are one of the largest users of these devices. Parameters such as fat mass, muscle mass, and body water can be measured easily using these meters. The mBCA 525 meters were manufactured by Seca for exclusive utilization in hospitals where large data sets and Bluetooth and Wi-Fi connectivity are required in devices. Devices like these are anticipated to see increased demand due to their convenience.

COVID-19 Impact on Bioimpedance Analyzers Market

The COVID-19 pandemic is anticipated to have a fairly positive impact on Bioimpedance Analyzers' market growth. In addition, owing to lockdowns and stay-at-home orders, people's lifestyles have become even more anxious than before. Also, people have maximum time on their hands than before. Owing to changes in lifestyle and the rising convenience of home-delivered food, consumers are eating carbo-hydrated drinks and non-healthy fat. With increased health consciousness, many are now turning toward home exercise regimens and fitness workshops. These advancements are probably to affect the demand for Bioimpedance Analyzers for monitoring health. Furthermore, many factors are turning the Bioimpedance Analyzers market growth, which includes a large pool of obese patients and rising frequency of metabolic disorders, technological developments, and growing consciousness for health and fitness. COVID-19 causes a breakdown of muscle mass and a declined appetite. This aids in malnutrition and significant loss of muscle mass. This is an important consideration for obese people, as they already have very low muscle mass. As per the OECD (Organization for Economic Co-operation and Development) Health Policy Studies in 2019, overweight and obesity rates have continued to grow to 58% of the adult population over OECD countries such as the United Kingdom Austria, Belgium, Czech Republic, Switzerland, Denmark, Estonia, Finland, France, Germany, Netherlands Greece, Hungary, Iceland, Ireland, Italy, and others. Therefore, assessing body composition and muscle mass during hospitalization and also afterward is highly important to protect patients as well as manage and monitor their improvement.

Market Dynamics And Factors For The Bioimpedance Analyzers Market

Drivers:

Digitization in the Healthcare Industry

Companies are targeted on the advancement of products that provide economic as well as clinical relevance to the overall business. This can be attributed to factors such as the growth of the healthcare industry in emerging economies and investments in healthcare information technology by governments as well as public sector organizations. Furthermore, growing healthcare spending, coupled with efforts by producers to provide innovative bioimpedance analyzers to serve the rising demand for advanced solutions in emerging economies, is also expected to turn the growth of the bioimpedance analyzers market in the upcoming years.

Growing Frequency of Lifestyle Diseases

Unhealthy lifestyles, such as sedentary work environments, utilization of junk food, and increased mobility automation have increased the frequency of different lifestyle diseases, such as obesity, high blood pressure, and diabetes. As per the CDC (Centres for Disease Control and Prevention), the global prevalence of obesity climbed to 42.4% in 2019 from 30.5% in 2000. Obesity is now termed a global crisis; an estimated 57.8% of all adults are anticipated to be categorized as obese by 2030 (Source: WHO, 2020). Additionally emerged economies, obesity is now an epidemic in low- and middle-income economies as well. Bioimpedance analyzers provide an accurate measurement of the amount of fat, muscle, and bone in the human body. This will be accelerating the growth of the bioimpedance analyzers market over the forecast period.

Restraints:

Variability In the Accuracy of Several Bioimpedance Analyzers

Even though the technology is developing, it is difficult to get accurate body fat measurements from the most commercially accessible body fat analyzers. The working of analyzers comprises passing an electrical current that follows the path of least resistance through the body. As fat contains less water, the fat-free mass has the least resistance to electrical current. Nevertheless, a large amount of fat underneath the skin is not determined by these analyzers. Additionally, body immunity varies among different ethnic groups and influences the accuracy of body composition analyzers.

Opportunities:

Developing Market Across the Asia Pacific and Latin America

Developing countries such as India, China, and Brazil are anticipated to observe maximum expansions in the bioimpedance analyzers market. This can be attributed to the growing frequency of lifestyle diseases, rising consciousness regarding health and obesity, and infrastructural developments in these economies. China is an important market in this regard, given its recent infrastructural developments, rapid economic growth, growing domestic demand, and public-private initiatives to support healthcare research. China's State Council sanctioned the 2016–2020 National Fitness Plan, which has encouraged all national fitness levels and increased sports participation.

Market Segmentation

Segmentation Analysis of Bioimpedance Analyzers Market:

Based on Product Type, the bioimpedance analyzers market is segmented into Single-frequency Analyzers, Dual-frequency Analyzers, Multi-frequency Analyzers, Bioimpedance Spectroscopy, Whole Body Bioimpedance Measurement, Body Segment Bioimpedance Measurement, Alternative Bioimpedance Analysis Method. The Multi-frequency Analyzers segment is expected to witness the maximum growth during the forecast period. The preference for multi-frequency bioimpedance analyzers is high among end-users as they can be utilized for both segmental and whole-body measurement, far from the single-frequency bioimpedance analyzers.

Based on the Modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment accounted for the largest bioimpedance analyzers market during the forecast period. The developments in and the rising demand for wireless technologies are major turning factors for this bioimpedance analyzers market.

Based on End-Users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs, and wellness centers, home users, and other end users. The fitness clubs and wellness centers segment are expected to hold the maximum share of the bioimpedance analyzers market over the forecast period. The growing number of fitness clubs and wellness centers and the rising consciousness regarding health and fitness over the world are the key driving factor for this bioimpedance analyzers market.

Based on the Application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment is anticipated to register the highest bioimpedance analyzers market share throughout the projected period. The large share of this segment can be attributed to the rising prevalence of obesity and metabolic disorders.

Regional Analysis of Bioimpedance Analyzers Market:

Based on the region, the bioimpedance analyzers market is classified into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

The North American region is expected to dominate the bioimpedance analyzers market during the forecast period. The maximum share of North America can be attributed to factors such as the rising obesity rate, government initiatives to motivate healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and rising number of health clubs and fitness centers.

In the Asia Pacific, the growing number of Chinese players in the market is anticipated to boost the growth of the bioimpedance analyzers market in China. Similarly, other local producers in the Asia Pacific region are anticipated to support the growth of the bioimpedance analyzers market over the forecast period.

Players Covered in Bioimpedance Analyzers market are :

•  Xiaomi (China)
•  Guangzhou Beautylife Electronic Technology Co.Ltd. (China)
•  Bodystat Ltd. (UK)
•  InBody (South Korea)
•  RJL Systems (US)
•  seca GmbH & Co. KG (Germany)
•  EVOLT 360 (Australia)
•  Chartered Electronics Co. Ltd. (China)
•  SELVAS Healthcare (South Korea)
•  Akern (Italy)
•  Maltron International (UK)
•  Fook Tin Group Holding Ltd. (China)
•  Biotekna (Italy)
•  Withings (France)
•  Omron Corporation (Japan)
•  Biodynamics Corporation (US)
•  Bioparhom (France)
•  Tanita Corporation (Japan)
•  Sino-Hero (Shenzhen)
•  Bio-Medical Electronics Co.Ltd. (China)
•  Lumsail Industrial Inc. (China)
•  and others.

Key Industry Developments In The Bioimpedance Analyzers Market

• In January 2016, Seca GmbH & co. kg, Hamburg, has presented a way to perform a mobile body composition analysis on patients in the supine position (Hall 12 at Stand 12 A 63). seca has made this a reality through a global innovation that ushers in a new era for lying bioimpedance measurement in terms of precision, medical validation, and handling. The seca mBCA 525 offers a complete analysis of body composition using medically validated data for diagnosis and therapy. The innovative centerpiece is a measuring mat as a multifunctional tool.
• In 2017, Selvas Healthcare introduced the ACCUNIQ BC380 artificial intelligence-based body composition analyzer globally.
• In July 2020, Omron Healthcare partnered with Mount Sinai Health System of New York to provide patients with its new VitalSight home blood pressure monitoring solution.
• In January 2020, InBody USA introduced the InBody 970 device. The device utilizes novel technology to categorize and analyze abdominal fat and total body water.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Modality
 3.3 By Application
 3.4 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Bioimpedance Analyzers Market by Type
 5.1 Bioimpedance Analyzers Market Overview Snapshot and Growth Engine
 5.2 Bioimpedance Analyzers Market Overview
 5.3 Single-frequency Analyzers
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Single-frequency Analyzers: Grographic Segmentation
 5.4 Dual-frequency Analyzers
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Dual-frequency Analyzers: Grographic Segmentation
 5.5 Multi-frequency Analyzers
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Multi-frequency Analyzers: Grographic Segmentation

Chapter 6: Bioimpedance Analyzers Market by Modality
 6.1 Bioimpedance Analyzers Market Overview Snapshot and Growth Engine
 6.2 Bioimpedance Analyzers Market Overview
 6.3 Wireless Bioimpedance Analyzers
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Wireless Bioimpedance Analyzers: Grographic Segmentation
 6.4 Wired Bioimpedance Analyzers
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Wired Bioimpedance Analyzers: Grographic Segmentation

Chapter 7: Bioimpedance Analyzers Market by Application
 7.1 Bioimpedance Analyzers Market Overview Snapshot and Growth Engine
 7.2 Bioimpedance Analyzers Market Overview
 7.3 Segmental Body Measurement
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Segmental Body Measurement: Grographic Segmentation
 7.4 Whole-body Measurement
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Whole-body Measurement: Grographic Segmentation

Chapter 8: Bioimpedance Analyzers Market by End-User
 8.1 Bioimpedance Analyzers Market Overview Snapshot and Growth Engine
 8.2 Bioimpedance Analyzers Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Grographic Segmentation
 8.4 Fitness Clubs & Wellness Centers
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Fitness Clubs & Wellness Centers: Grographic Segmentation
 8.5 Home Users
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Home Users: Grographic Segmentation
 8.6 Other
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Other: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Bioimpedance Analyzers Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Bioimpedance Analyzers Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Bioimpedance Analyzers Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 XIAOMI
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO.LTD.
 9.4 BODYSTAT LTD.
 9.5 INBODY
 9.6 RJL SYSTEMS
 9.7 SECA GMBH & CO. KG
 9.8 EVOLT 360
 9.9 CHARTERED ELECTRONICS CO. LTD.
 9.10 SELVAS HEALTHCARE
 9.11 AKERN
 9.12 MALTRON INTERNATIONAL
 9.13 FOOK TIN GROUP HOLDING LTD.
 9.14 BIOTEKNA
 9.15 WITHINGS
 9.16 OMRON CORPORATION
 9.17 BIODYNAMICS CORPORATION
 9.18 BIOPARHOM
 9.19 TANITA CORPORATION
 9.20 SINO-HERO
 9.21 BIO-MEDICAL ELECTRONICS CO.LTD.
 9.22 LUMSAIL INDUSTRIAL INC.
 9.23 OTHER MAJOR PLAYERS

Chapter 10: Global Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Single-frequency Analyzers
  10.2.2 Dual-frequency Analyzers
  10.2.3 Multi-frequency Analyzers
 10.3 Historic and Forecasted Market Size By Modality
  10.3.1 Wireless Bioimpedance Analyzers
  10.3.2 Wired Bioimpedance Analyzers
 10.4 Historic and Forecasted Market Size By Application
  10.4.1 Segmental Body Measurement
  10.4.2 Whole-body Measurement
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Hospitals
  10.5.2 Fitness Clubs & Wellness Centers
  10.5.3 Home Users
  10.5.4 Other

Chapter 11: North America Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Single-frequency Analyzers
  11.4.2 Dual-frequency Analyzers
  11.4.3 Multi-frequency Analyzers
 11.5 Historic and Forecasted Market Size By Modality
  11.5.1 Wireless Bioimpedance Analyzers
  11.5.2 Wired Bioimpedance Analyzers
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Segmental Body Measurement
  11.6.2 Whole-body Measurement
 11.7 Historic and Forecasted Market Size By End-User
  11.7.1 Hospitals
  11.7.2 Fitness Clubs & Wellness Centers
  11.7.3 Home Users
  11.7.4 Other
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Single-frequency Analyzers
  12.4.2 Dual-frequency Analyzers
  12.4.3 Multi-frequency Analyzers
 12.5 Historic and Forecasted Market Size By Modality
  12.5.1 Wireless Bioimpedance Analyzers
  12.5.2 Wired Bioimpedance Analyzers
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Segmental Body Measurement
  12.6.2 Whole-body Measurement
 12.7 Historic and Forecasted Market Size By End-User
  12.7.1 Hospitals
  12.7.2 Fitness Clubs & Wellness Centers
  12.7.3 Home Users
  12.7.4 Other
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Single-frequency Analyzers
  13.4.2 Dual-frequency Analyzers
  13.4.3 Multi-frequency Analyzers
 13.5 Historic and Forecasted Market Size By Modality
  13.5.1 Wireless Bioimpedance Analyzers
  13.5.2 Wired Bioimpedance Analyzers
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Segmental Body Measurement
  13.6.2 Whole-body Measurement
 13.7 Historic and Forecasted Market Size By End-User
  13.7.1 Hospitals
  13.7.2 Fitness Clubs & Wellness Centers
  13.7.3 Home Users
  13.7.4 Other
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Single-frequency Analyzers
  14.4.2 Dual-frequency Analyzers
  14.4.3 Multi-frequency Analyzers
 14.5 Historic and Forecasted Market Size By Modality
  14.5.1 Wireless Bioimpedance Analyzers
  14.5.2 Wired Bioimpedance Analyzers
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Segmental Body Measurement
  14.6.2 Whole-body Measurement
 14.7 Historic and Forecasted Market Size By End-User
  14.7.1 Hospitals
  14.7.2 Fitness Clubs & Wellness Centers
  14.7.3 Home Users
  14.7.4 Other
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Bioimpedance Analyzers Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Single-frequency Analyzers
  15.4.2 Dual-frequency Analyzers
  15.4.3 Multi-frequency Analyzers
 15.5 Historic and Forecasted Market Size By Modality
  15.5.1 Wireless Bioimpedance Analyzers
  15.5.2 Wired Bioimpedance Analyzers
 15.6 Historic and Forecasted Market Size By Application
  15.6.1 Segmental Body Measurement
  15.6.2 Whole-body Measurement
 15.7 Historic and Forecasted Market Size By End-User
  15.7.1 Hospitals
  15.7.2 Fitness Clubs & Wellness Centers
  15.7.3 Home Users
  15.7.4 Other
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOIMPEDANCE ANALYZERS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOIMPEDANCE ANALYZERS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOIMPEDANCE ANALYZERS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOIMPEDANCE ANALYZERS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOIMPEDANCE ANALYZERS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOIMPEDANCE ANALYZERS MARKET BY TYPE
TABLE 008. SINGLE-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 009. DUAL-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 010. MULTI-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 011. BIOIMPEDANCE ANALYZERS MARKET BY MODALITY
TABLE 012. WIRELESS BIOIMPEDANCE ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 013. WIRED BIOIMPEDANCE ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 014. BIOIMPEDANCE ANALYZERS MARKET BY APPLICATION
TABLE 015. SEGMENTAL BODY MEASUREMENT MARKET OVERVIEW (2016-2028)
TABLE 016. WHOLE-BODY MEASUREMENT MARKET OVERVIEW (2016-2028)
TABLE 017. BIOIMPEDANCE ANALYZERS MARKET BY END-USER
TABLE 018. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 019. FITNESS CLUBS & WELLNESS CENTERS MARKET OVERVIEW (2016-2028)
TABLE 020. HOME USERS MARKET OVERVIEW (2016-2028)
TABLE 021. OTHER MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (2016-2028)
TABLE 024. NORTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY END-USER (2016-2028)
TABLE 026. N BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE BIOIMPEDANCE ANALYZERS MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (2016-2028)
TABLE 029. EUROPE BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (2016-2028)
TABLE 030. EUROPE BIOIMPEDANCE ANALYZERS MARKET, BY END-USER (2016-2028)
TABLE 031. BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY (2016-2028)
TABLE 032. ASIA PACIFIC BIOIMPEDANCE ANALYZERS MARKET, BY TYPE (2016-2028)
TABLE 033. ASIA PACIFIC BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (2016-2028)
TABLE 034. ASIA PACIFIC BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (2016-2028)
TABLE 035. ASIA PACIFIC BIOIMPEDANCE ANALYZERS MARKET, BY END-USER (2016-2028)
TABLE 036. BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA BIOIMPEDANCE ANALYZERS MARKET, BY TYPE (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA BIOIMPEDANCE ANALYZERS MARKET, BY END-USER (2016-2028)
TABLE 041. BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY TYPE (2016-2028)
TABLE 043. SOUTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (2016-2028)
TABLE 044. SOUTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (2016-2028)
TABLE 045. SOUTH AMERICA BIOIMPEDANCE ANALYZERS MARKET, BY END-USER (2016-2028)
TABLE 046. BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY (2016-2028)
TABLE 047. XIAOMI: SNAPSHOT
TABLE 048. XIAOMI: BUSINESS PERFORMANCE
TABLE 049. XIAOMI: PRODUCT PORTFOLIO
TABLE 050. XIAOMI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO.LTD.: SNAPSHOT
TABLE 051. GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO.LTD.: BUSINESS PERFORMANCE
TABLE 052. GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO.LTD.: PRODUCT PORTFOLIO
TABLE 053. GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO.LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. BODYSTAT LTD.: SNAPSHOT
TABLE 054. BODYSTAT LTD.: BUSINESS PERFORMANCE
TABLE 055. BODYSTAT LTD.: PRODUCT PORTFOLIO
TABLE 056. BODYSTAT LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. INBODY: SNAPSHOT
TABLE 057. INBODY: BUSINESS PERFORMANCE
TABLE 058. INBODY: PRODUCT PORTFOLIO
TABLE 059. INBODY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. RJL SYSTEMS: SNAPSHOT
TABLE 060. RJL SYSTEMS: BUSINESS PERFORMANCE
TABLE 061. RJL SYSTEMS: PRODUCT PORTFOLIO
TABLE 062. RJL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. SECA GMBH & CO. KG: SNAPSHOT
TABLE 063. SECA GMBH & CO. KG: BUSINESS PERFORMANCE
TABLE 064. SECA GMBH & CO. KG: PRODUCT PORTFOLIO
TABLE 065. SECA GMBH & CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. EVOLT 360: SNAPSHOT
TABLE 066. EVOLT 360: BUSINESS PERFORMANCE
TABLE 067. EVOLT 360: PRODUCT PORTFOLIO
TABLE 068. EVOLT 360: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. CHARTERED ELECTRONICS CO. LTD.: SNAPSHOT
TABLE 069. CHARTERED ELECTRONICS CO. LTD.: BUSINESS PERFORMANCE
TABLE 070. CHARTERED ELECTRONICS CO. LTD.: PRODUCT PORTFOLIO
TABLE 071. CHARTERED ELECTRONICS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. SELVAS HEALTHCARE: SNAPSHOT
TABLE 072. SELVAS HEALTHCARE: BUSINESS PERFORMANCE
TABLE 073. SELVAS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 074. SELVAS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. AKERN: SNAPSHOT
TABLE 075. AKERN: BUSINESS PERFORMANCE
TABLE 076. AKERN: PRODUCT PORTFOLIO
TABLE 077. AKERN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. MALTRON INTERNATIONAL: SNAPSHOT
TABLE 078. MALTRON INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 079. MALTRON INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 080. MALTRON INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. FOOK TIN GROUP HOLDING LTD.: SNAPSHOT
TABLE 081. FOOK TIN GROUP HOLDING LTD.: BUSINESS PERFORMANCE
TABLE 082. FOOK TIN GROUP HOLDING LTD.: PRODUCT PORTFOLIO
TABLE 083. FOOK TIN GROUP HOLDING LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. BIOTEKNA: SNAPSHOT
TABLE 084. BIOTEKNA: BUSINESS PERFORMANCE
TABLE 085. BIOTEKNA: PRODUCT PORTFOLIO
TABLE 086. BIOTEKNA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. WITHINGS: SNAPSHOT
TABLE 087. WITHINGS: BUSINESS PERFORMANCE
TABLE 088. WITHINGS: PRODUCT PORTFOLIO
TABLE 089. WITHINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. OMRON CORPORATION: SNAPSHOT
TABLE 090. OMRON CORPORATION: BUSINESS PERFORMANCE
TABLE 091. OMRON CORPORATION: PRODUCT PORTFOLIO
TABLE 092. OMRON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. BIODYNAMICS CORPORATION: SNAPSHOT
TABLE 093. BIODYNAMICS CORPORATION: BUSINESS PERFORMANCE
TABLE 094. BIODYNAMICS CORPORATION: PRODUCT PORTFOLIO
TABLE 095. BIODYNAMICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. BIOPARHOM: SNAPSHOT
TABLE 096. BIOPARHOM: BUSINESS PERFORMANCE
TABLE 097. BIOPARHOM: PRODUCT PORTFOLIO
TABLE 098. BIOPARHOM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. TANITA CORPORATION: SNAPSHOT
TABLE 099. TANITA CORPORATION: BUSINESS PERFORMANCE
TABLE 100. TANITA CORPORATION: PRODUCT PORTFOLIO
TABLE 101. TANITA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. SINO-HERO: SNAPSHOT
TABLE 102. SINO-HERO: BUSINESS PERFORMANCE
TABLE 103. SINO-HERO: PRODUCT PORTFOLIO
TABLE 104. SINO-HERO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. BIO-MEDICAL ELECTRONICS CO.LTD.: SNAPSHOT
TABLE 105. BIO-MEDICAL ELECTRONICS CO.LTD.: BUSINESS PERFORMANCE
TABLE 106. BIO-MEDICAL ELECTRONICS CO.LTD.: PRODUCT PORTFOLIO
TABLE 107. BIO-MEDICAL ELECTRONICS CO.LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. LUMSAIL INDUSTRIAL INC.: SNAPSHOT
TABLE 108. LUMSAIL INDUSTRIAL INC.: BUSINESS PERFORMANCE
TABLE 109. LUMSAIL INDUSTRIAL INC.: PRODUCT PORTFOLIO
TABLE 110. LUMSAIL INDUSTRIAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 111. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 112. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 113. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY TYPE
FIGURE 012. SINGLE-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 013. DUAL-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 014. MULTI-FREQUENCY ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 015. BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY MODALITY
FIGURE 016. WIRELESS BIOIMPEDANCE ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 017. WIRED BIOIMPEDANCE ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 018. BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY APPLICATION
FIGURE 019. SEGMENTAL BODY MEASUREMENT MARKET OVERVIEW (2016-2028)
FIGURE 020. WHOLE-BODY MEASUREMENT MARKET OVERVIEW (2016-2028)
FIGURE 021. BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY END-USER
FIGURE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 023. FITNESS CLUBS & WELLNESS CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 024. HOME USERS MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA BIOIMPEDANCE ANALYZERS MARKET OVERVIEW BY COUNTRY (2016-2028)